1
|
Kuzovlev AS, Zybalov MD, Golovin AV, Gureev MA, Kasatkina MA, Biryukov MV, Belik AR, Silonov SA, Yunin MA, Zigangirova NA, Reshetnikov VV, Isakova YE, Porozov YB, Ivanov RA. Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators-Inhibitors of Bacterial Cystathionine γ-Lyase. Int J Mol Sci 2023; 24:16331. [PMID: 38003521 PMCID: PMC10671052 DOI: 10.3390/ijms242216331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 11/08/2023] [Accepted: 11/13/2023] [Indexed: 11/26/2023] Open
Abstract
Over the past decades, the problem of bacterial resistance to most antibiotics has become a serious threat to patients' survival. Nevertheless, antibiotics of a novel class have not been approved since the 1980s. The development of antibiotic potentiators is an appealing alternative to the challenging process of searching for new antimicrobials. Production of H2S-one of the leading defense mechanisms crucial for bacterial survival-can be influenced by the inhibition of relevant enzymes: bacterial cystathionine γ-lyase (bCSE), bacterial cystathionine β-synthase (bCBS), or 3-mercaptopyruvate sulfurtransferase (MST). The first one makes the main contribution to H2S generation. Herein, we present data on the synthesis, in silico analyses, and enzymatic and microbiological assays of novel bCSE inhibitors. Combined molecular docking and molecular dynamics analyses revealed a novel binding mode of these ligands to bCSE. Lead compound 2a manifested strong potentiating activity when applied in combination with some commonly used antibiotics against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. The compound was found to have favorable in vitro absorption, distribution, metabolism, excretion, and toxicity parameters. The high effectiveness and safety of compound 2a makes it a promising candidate for enhancing the activity of antibiotics against high-priority pathogens.
Collapse
Affiliation(s)
- Andrey S. Kuzovlev
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Mikhail D. Zybalov
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Andrey V. Golovin
- Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1/73 Leninskie gori St., 119234 Moscow, Russia;
- Laboratory of Bioinformatics, Center of AI and Information Technologies, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.A.G.); (Y.B.P.)
| | - Maxim A. Gureev
- Laboratory of Bioinformatics, Center of AI and Information Technologies, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.A.G.); (Y.B.P.)
- Laboratory of Bio- and Chemoinformatics, Institute of Biodesign and Modeling of Complex Systems, I.M. Sechenov First Moscow State Medical University, 8/2 Trubetskaya, 119991 Moscow, Russia
| | - Mariia A. Kasatkina
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Mikhail V. Biryukov
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
- Faculty of Biology, Lomonosov Moscow State University, 1/12 Leninskie gori St., 119234 Moscow, Russia
| | - Albina R. Belik
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Sergey A. Silonov
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
- Laboratory of Structural Dynamics, Stability and Folding of Proteins, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Ave., 194064 St. Petersburg, Russia
| | - Maxim A. Yunin
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Nailya A. Zigangirova
- Medical Microbiology Department, Laboratory of Chlamydiosis, National Research Center for Epidemiology and Microbiology Named after N. F. Gamaleya, 18 Gamaleya St., 123098 Moscow, Russia;
| | - Vasiliy V. Reshetnikov
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
- Institute of Cytology and Genetics, Siberian Branch of RAS, 10 Akademika Lavrentyeva, 630090 Novosibirsk, Russia
| | - Yulia E. Isakova
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| | - Yuri B. Porozov
- Laboratory of Bioinformatics, Center of AI and Information Technologies, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.A.G.); (Y.B.P.)
- Laboratory of Bio- and Chemoinformatics, Institute of Biodesign and Modeling of Complex Systems, I.M. Sechenov First Moscow State Medical University, 8/2 Trubetskaya, 119991 Moscow, Russia
| | - Roman A. Ivanov
- Translational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia; (M.D.Z.); (M.A.K.); (M.V.B.); (A.R.B.); (S.A.S.); (M.A.Y.); (V.V.R.); (Y.E.I.); (R.A.I.)
| |
Collapse
|
2
|
Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, Thareja S, Yadav JP, Pathak P, Grishina M, Verma A, Khalilullah H, Jaremko M, Emwas AH, Kumar P. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals (Basel) 2023; 16:299. [PMID: 37259442 PMCID: PMC9965678 DOI: 10.3390/ph16020299] [Citation(s) in RCA: 37] [Impact Index Per Article: 37.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 01/26/2023] [Accepted: 01/28/2023] [Indexed: 07/30/2023] Open
Abstract
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, and suffer from resistance. So, there is a dire need to develop safer and target-specific anticancer drugs. More than 85% of all physiologically active pharmaceuticals are heterocycles or contain at least one heteroatom. Nitrogen heterocycles constituting the most common heterocyclic framework. In this study, we have compiled the FDA approved heterocyclic drugs with nitrogen atoms and their pharmacological properties. Moreover, we have reported nitrogen containing heterocycles, including pyrimidine, quinolone, carbazole, pyridine, imidazole, benzimidazole, triazole, β-lactam, indole, pyrazole, quinazoline, quinoxaline, isatin, pyrrolo-benzodiazepines, and pyrido[2,3-d]pyrimidines, which are used in the treatment of different types of cancer, concurrently covering the biochemical mechanisms of action and cellular targets.
Collapse
Affiliation(s)
- Adarsh Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Ankit Kumar Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Harshwardhan Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Veena Vijayan
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Deepak Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jashwanth Naik
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Suresh Thareja
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jagat Pal Yadav
- Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, Rama University, Kanpur 209217, India
| | - Prateek Pathak
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Maria Grishina
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Amita Verma
- Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
| | - Habibullah Khalilullah
- Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unayzah 51911, Saudi Arabia
| | - Mariusz Jaremko
- Smart-Health Initiative and Red Sea Research Center, Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Abdul-Hamid Emwas
- Core Labs, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Pradeep Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| |
Collapse
|
3
|
Chen D, Xu L, Yu Y, Mo Q, Qi X, Liu C. Triflylpyridinium Enables Rapid and Scalable Controlled Reduction of Carboxylic Acids to Aldehydes using Pinacolborane. Angew Chem Int Ed Engl 2023; 62:e202215168. [PMID: 36378536 DOI: 10.1002/anie.202215168] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Indexed: 11/16/2022]
Abstract
Building up new and efficient methods for the controlled conversion of carboxylic acids to aldehydes is important. Herein, we report a rapid, modular and scalable method for the conversion of carboxylic acids to aldehydes using pinacolborane at ambient temperature, in which a triflylpyridinium reagent is used. The conversion of carboxylic acid to intermediate acylpyridinium by triflylpyridinium is new. A binary pyridine-coordinated boronium complex is generated after reduction. The unprecedented reduction of the acylpyridinium by HBpin opens up a practically direct synthesis of aldehydes from carboxylic acids. Theoretical studies indicate that the reduction of acylpyridinium requires a lower activation free energy than that of the product aldehyde. The synthetic advantage of this protocol is further highlighted by the scalable synthesis of aldehyde via continuous flow process. Configuration retention for chiral acids are presented in those syntheses.
Collapse
Affiliation(s)
- Du Chen
- State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, P. R. China.,University of Chinese Academy of Sciences, Beijing, 100049, P. R. China
| | - Liangxuan Xu
- State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, P. R. China.,University of Chinese Academy of Sciences, Beijing, 100049, P. R. China
| | - Yi Yu
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China
| | - Qinliang Mo
- State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, P. R. China
| | - Xiaotian Qi
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China
| | - Chao Liu
- State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, P. R. China
| |
Collapse
|
4
|
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals (Basel) 2022; 15:ph15091071. [PMID: 36145292 PMCID: PMC9500727 DOI: 10.3390/ph15091071] [Citation(s) in RCA: 34] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 08/19/2022] [Accepted: 08/22/2022] [Indexed: 11/16/2022] Open
Abstract
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in recent drug discovery that involves the combination of two drug pharmacophores into a single molecule. The hybrid molecule acts through distinct modes of action on several targets at a given time with more efficacy and less susceptibility to resistance. Thus, there is a huge scope for using hybrid compounds to tackle the present difficulties in cancer medicine. Recent work has applied this technique to uncover some interesting molecules with substantial anticancer properties. In this study, we report data on numerous promising hybrid anti-proliferative/anti-tumor agents developed over the previous 10 years (2011–2021). It includes quinazoline, indole, carbazole, pyrimidine, quinoline, quinone, imidazole, selenium, platinum, hydroxamic acid, ferrocene, curcumin, triazole, benzimidazole, isatin, pyrrolo benzodiazepine (PBD), chalcone, coumarin, nitrogen mustard, pyrazole, and pyridine-based anticancer hybrids produced via molecular hybridization techniques. Overall, this review offers a clear indication of the potential benefits of merging pharmacophoric subunits from multiple different known chemical prototypes to produce more potent and precise hybrid compounds. This provides valuable knowledge for researchers working on complex diseases such as cancer.
Collapse
|
5
|
Benzodiazepines: Drugs with Chemical Skeletons Suitable for the Preparation of Metallacycles with Potential Pharmacological Activity. Molecules 2021; 26:molecules26092796. [PMID: 34068533 PMCID: PMC8125983 DOI: 10.3390/molecules26092796] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 05/06/2021] [Accepted: 05/07/2021] [Indexed: 12/02/2022] Open
Abstract
The synthesis of organometallic compounds with potential pharmacological activity has attracted the attention of many research groups, aiming to take advantage of aspects that the presence of the metal-carbon bond can bring to the design of new pharmaceutical drugs. In this context, we have gathered studies reported in the literature in which psychoactive benzodiazepine drugs were used as ligands in the preparation of organometallic and metal complexes and provide details on some of their biological effects. We also highlight that most commonly known benzodiazepine-based drugs display molecular features that allow the preparation of metallacycles via C-H activation. These organometallic compounds merit further attention regarding their potential biological effects, not only in terms of psychoactive drugs but also in the search for drug replacements, for example, for cancer treatments.
Collapse
|
6
|
Ridha Ben Ali, Omrani R, Ben Othman A, Raddaoui A, Ben Akacha A, El May MV. Synthesis, Design, and Biological Evaluation of Novel Diethylphenylcarbamothioylphosphonate. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2021. [DOI: 10.1134/s1068162021010192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
7
|
Ali RB, Omrani R, Akacha AB, Dziri C, El May MV. Development and validation of a colorimetric method for the quantitative analysis of thioamide derivatives. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2019; 220:117154. [PMID: 31132665 DOI: 10.1016/j.saa.2019.117154] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Revised: 05/13/2019] [Accepted: 05/21/2019] [Indexed: 06/09/2023]
Abstract
Thioamides (Thm) have diverse biological activities. This work presents the development and validation of simple, rapid and accurate spectrophotometric method for the analysis of Thm derivatives in pure form and in plasma. This spectrophotometric method has not been used before for determination of Thm. A review of the literature revealed that the monitoring of S- group assay is based on the reaction with DTNB according to the Ellman method to form a yellow complex which absorbs at 412 nm. To assay the thioamides according to this method it is necessary to make the basic medium have S- to react with the DTNB. Experimental conditions affecting the color development were studied and optimized. The proposed spectrophotometric procedures were effectively validated with respect to linearity, ranges, precision, accuracy, specificity, robustness, detection and quantification limits. Calibration curves of the formed colored product with DTNB showed good linear relationships over the concentration ranges (0, 50, 100, 500, 1000, 1500 mg/L). The proposed method was successfully applied to the assay of Thm monitoring with good accuracy. The principal advantages of the proposed method were rapidity and suitability for the routine quality control assay of the drug alone and in monitoring form without interference.
Collapse
Affiliation(s)
- Ridha Ben Ali
- Experimental Medicine Unit, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia; Histology, Embryology and Cell Biology Laboratory, Unit Research N° 17/ES/13, Faculty of Medicine of Tunis, University of Tunis El Manar, 2092 Tunis, Tunisia.
| | - Rania Omrani
- Laboratory Selective Organic & Heterocyclic Synthesis Biological Activity Evaluation, Department of Chemistry, Faculty of Sciences, University of Tunis El Manar, 2092 Tunis, Tunisia.
| | - Azaiez Ben Akacha
- Laboratory Selective Organic & Heterocyclic Synthesis Biological Activity Evaluation, Department of Chemistry, Faculty of Sciences, University of Tunis El Manar, 2092 Tunis, Tunisia
| | - Chadli Dziri
- Experimental Medicine Unit, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
| | - Michèle Véronique El May
- Experimental Medicine Unit, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia; Histology, Embryology and Cell Biology Laboratory, Unit Research N° 17/ES/13, Faculty of Medicine of Tunis, University of Tunis El Manar, 2092 Tunis, Tunisia
| |
Collapse
|
8
|
Dantas RF, Evangelista TCS, Neves BJ, Senger MR, Andrade CH, Ferreira SB, Silva-Junior FP. Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings. Expert Opin Drug Discov 2019; 14:1269-1282. [DOI: 10.1080/17460441.2019.1654453] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Rafael Ferreira Dantas
- LaBECFar – Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | - Tereza Cristina Santos Evangelista
- LaSOPB – Laboratório de Síntese Orgânica e Prospecção Biológica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Bruno Junior Neves
- LabChem – Laboratory of Cheminformatics, Centro Universitário de Anápolis, UniEVANGÉLICA, Anápolis, Brazil
| | - Mario Roberto Senger
- LaBECFar – Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | - Carolina Horta Andrade
- LabMol – Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia, Brazil
| | - Sabrina Baptista Ferreira
- LaSOPB – Laboratório de Síntese Orgânica e Prospecção Biológica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Floriano Paes Silva-Junior
- LaBECFar – Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| |
Collapse
|
9
|
Liu D, Luo P, Ge J, Jiang Z, Peng Y, Ding Q. Synthesis of 2-Arylbenzothiazole and 2-Arylthiazole Derivatives via a Ru-Catalyzed meta-Selective C–H Nitration Reaction. J Org Chem 2019; 84:12784-12791. [DOI: 10.1021/acs.joc.9b01194] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- Deming Liu
- Key Laboratory of Small Functional Organic Molecules, Ministry of Education and Jiangxi’s Key Laboratory of Green Chemistry, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China
| | - Puying Luo
- Department of Obstetrics and Gynecology, Jiangxi Provincial people’s Hospital, Nanchang, Jiangxi 330006, P. R. China
| | - Junying Ge
- Key Laboratory of Small Functional Organic Molecules, Ministry of Education and Jiangxi’s Key Laboratory of Green Chemistry, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China
| | - Zilin Jiang
- Key Laboratory of Small Functional Organic Molecules, Ministry of Education and Jiangxi’s Key Laboratory of Green Chemistry, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China
| | - Yiyuan Peng
- Key Laboratory of Small Functional Organic Molecules, Ministry of Education and Jiangxi’s Key Laboratory of Green Chemistry, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China
| | - Qiuping Ding
- Key Laboratory of Small Functional Organic Molecules, Ministry of Education and Jiangxi’s Key Laboratory of Green Chemistry, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China
| |
Collapse
|
10
|
Li G, D’Auria J, Kumar Katakam N, W. Seifert C. Efficient Synthesis of Methyl (S)-4-(1-Methylpyrrolidin-2-yl)-3-oxobutanoate as the Key Intermediate for Tropane Alkaloid Biosynthesis with Optically Active Form. HETEROCYCLES 2019. [DOI: 10.3987/com-18-s(f)4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
11
|
Ma C, Du K, Zhao Y, Zhang L, Hu B, Cheng M. Pyrrolo[2,1-c][1,4] benzodiazepine-3,11-diones protect SHSY-5Y cells from Cd-induced apoptosis involving suppression of endoplasmic reticulum stress. Bioorg Med Chem 2018; 26:5151-5158. [DOI: 10.1016/j.bmc.2018.09.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Revised: 09/07/2018] [Accepted: 09/10/2018] [Indexed: 11/24/2022]
|
12
|
Dadmal TL, Appalanaidu K, Kumbhare RM, Mondal T, Ramaiah MJ, Bhadra MP. Synthesis and biological evaluation of triazole and isoxazole-tagged benzothiazole/benzoxazole derivatives as potent cytotoxic agents. NEW J CHEM 2018. [DOI: 10.1039/c8nj01249k] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Cancer is a major health problem and the most upsetting disease in humans, leading to death in both developed and developing countries.
Collapse
Affiliation(s)
- Tulshiram L. Dadmal
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
- Government of Maharashtra's
| | - K. Appalanaidu
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
| | - Ravindra M. Kumbhare
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
| | - Tanmoy Mondal
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
| | - M. Janaki Ramaiah
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
- School of Chemical and Biotechnology
| | - Manika Pal Bhadra
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
| |
Collapse
|
13
|
Varvounis G. An Update on the Synthesis of Pyrrolo[1,4]benzodiazepines. Molecules 2016; 21:154. [PMID: 26828475 PMCID: PMC6273195 DOI: 10.3390/molecules21020154] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2015] [Revised: 12/23/2015] [Accepted: 01/05/2016] [Indexed: 01/12/2023] Open
Abstract
Pyrrolo[1,4]benzodiazepines are tricyclic compounds that are considered “privileged structures” since they possess a wide range of biological activities. The first encounter with these molecules was the isolation of anthramycin from cultures of Streptomyces, followed by determination of the X-ray crystal structure of the molecule and a study of its interaction with DNA. This opened up an intensive synthetic and biological study of the pyrrolo[2,1-c][1,4]benzodiazepines that has culminated in the development of the dimer SJG-136, at present in Phase II clinical trials. The synthetic efforts have brought to light some new synthetic methodology, while the contemporary work is focused on building trimeric pyrrolo[2,1-c][1,4]benzodiazepines linked together by various heterocyclic and aliphatic chains. It is the broad spectrum of biological activities of pyrrolo[1,2-a][1,4]benzodiazepines that has maintained the interest of researchers to date whereas several derivatives of the even less studied pyrrolo[1,2-d][1,4]benzodiazepines were found to be potent non-nucleoside HIV-1 reverse transcriptase inhibitors. The present review is an update on the synthesis of pyrrolo[2,1-c][1,4]benzodiazepines since the last major review of 2011, while the overview of the synthesis of the other two tricyclic isomers is comprehensive.
Collapse
Affiliation(s)
- George Varvounis
- Department of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 451 10 Ioannina, Greece.
| |
Collapse
|
14
|
Barros WBZG, da Silva AHQ, Barbosa ASL, Nunes ÁM, Reys JRM, de Araújo-Filho HG, de Souza Siqueira Quintans J, Quintans-Júnior LJ, Pfeffer M, Dos Santos Malta VR, Meneghetti MR. Palladium-benzodiazepine derivatives as promising metallodrugs for the development of antiepileptic therapies. J Inorg Biochem 2015; 155:129-35. [PMID: 26687024 DOI: 10.1016/j.jinorgbio.2015.11.024] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 10/29/2015] [Accepted: 11/30/2015] [Indexed: 12/18/2022]
Abstract
We synthesized two organometallic diazepam-palladium(II) derivatives by C-H activation of diazepam (DZP) with palladium salts, i.e., PdCl2 and Pd(OAc)2 (OAc=acetate). Both compounds obtained are air stable and were isolated in good yields. The anticonvulsant potential of the complexes, labeled [(DZP)PdCl]2 and [(DZP)PdOAc]2, was evaluated through two animal models: pentylenetetrazole (PTZ)- and picrotoxin (PTX)-induced convulsions. The organometallic DZP-palladium(II) acetate complex, [(DZP)PdOAc]2, significantly increased (p<0.01 or p<0.001) latencies and protected the animals against convulsions induced by PTZ and PTX, while the analogous chloro derivative, [(DZP)PdCl]2, was effective (p<0.01) only in the PTZ model. These effects appear to be mediated through the GABAergic system. The possible mechanism of action of the DZP-palladium(II) complexes was also confirmed with the use of flumazenil (FLU), a GABAA-benzodiazepine receptor complex site antagonist. Herein, we present the first report of the anticonvulsant properties of organometallic DZP-palladium(II) complexes as well as evidence that these compounds may play an important role in the study of new drugs to treat patients with epilepsy.
Collapse
Affiliation(s)
- Walleska Bismaida Zacarias Galvão Barros
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| | - Allysson Haide Queiroz da Silva
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| | - Ana Soraya Lima Barbosa
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil; Laboratoire de Chimie et Systémique Organo-Métalliques, Institut de Chimie, UMR7177, 4 rue Blaise Pascal, Strasbourg 67000, France.
| | - Ábner Magalhães Nunes
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| | - José Rui Machado Reys
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| | - Heitor Gomes de Araújo-Filho
- Laboratório de Neurociências e Ensaios Farmacológicos (LANEF), Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), Av. Marechal Rondom, s/n, São Cristóvão, Sergipe CEP 49.000-100, Brazil.
| | - Jullyana de Souza Siqueira Quintans
- Laboratório de Neurociências e Ensaios Farmacológicos (LANEF), Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), Av. Marechal Rondom, s/n, São Cristóvão, Sergipe CEP 49.000-100, Brazil.
| | - Lucindo José Quintans-Júnior
- Laboratório de Neurociências e Ensaios Farmacológicos (LANEF), Departamento de Fisiologia, Universidade Federal de Sergipe (UFS), Av. Marechal Rondom, s/n, São Cristóvão, Sergipe CEP 49.000-100, Brazil.
| | - Michel Pfeffer
- Laboratoire de Chimie et Systémique Organo-Métalliques, Institut de Chimie, UMR7177, 4 rue Blaise Pascal, Strasbourg 67000, France.
| | - Valéria Rodrigues Dos Santos Malta
- Laboratório de Cristalografia e Modelagem Molecular (LaboCrMM), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| | - Mario Roberto Meneghetti
- Grupo de Catálise e Reatividade Química (GCaR), Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Av. Lourival de Melo Mota, s/n, Maceió, Alagoas CEP: 57.072-970, Brazil.
| |
Collapse
|
15
|
Omrani R, Ben Amor F, Bahri M, Efrit ML, Ben Akacha A. Synthesis and structural Studies of phosphonothioamidates. PHOSPHORUS SULFUR 2015. [DOI: 10.1080/10426507.2015.1024783] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- R. Omrani
- Department of Chemistry, Faculty of Science, Laboratory of Heterocyclic and Organic Synthesis, El Manar, 2092, Tunisia
| | - F. Ben Amor
- Department of Chemistry, Faculty of Science, Laboratory of Materials and Crystalloid Chemistry, El Manar, 2092, Tunisia
| | - M. Bahri
- Department of Physics, Faculty of Science, Laboratory of Atomic Spectroscopic, Molecular and Applications, El Manar, 2092, Tunisia
| | - M. L. Efrit
- Department of Chemistry, Faculty of Science, Laboratory of Heterocyclic and Organic Synthesis, El Manar, 2092, Tunisia
| | - A. Ben Akacha
- Department of Chemistry, Faculty of Science, Laboratory of Heterocyclic and Organic Synthesis, El Manar, 2092, Tunisia
| |
Collapse
|
16
|
Arora A, Teegardin KA, Weaver JD. Reductive Alkylation of 2-Bromoazoles via Photoinduced Electron Transfer: A Versatile Strategy to Csp2–Csp3 Coupled Products. Org Lett 2015; 17:3722-5. [DOI: 10.1021/acs.orglett.5b01711] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- Amandeep Arora
- Department
of Chemistry, Oklahoma State University, Stillwater, Oklahoma 74078, United States
| | - Kip A. Teegardin
- Department
of Chemistry, Oklahoma State University, Stillwater, Oklahoma 74078, United States
| | - Jimmie D. Weaver
- Department
of Chemistry, Oklahoma State University, Stillwater, Oklahoma 74078, United States
| |
Collapse
|
17
|
Hemming K, Chambers CS, Hamasharif MS, João H, Khan MN, Patel N, Airley R, Day S. Azide based routes to tetrazolo and oxadiazolo derivatives of pyrrolobenzodiazepines and pyrrolobenzothiadiazepines. Tetrahedron 2014. [DOI: 10.1016/j.tet.2014.07.050] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
18
|
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014; 77:422-87. [PMID: 24685980 DOI: 10.1016/j.ejmech.2014.03.018] [Citation(s) in RCA: 306] [Impact Index Per Article: 30.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2013] [Revised: 03/02/2014] [Accepted: 03/06/2014] [Indexed: 12/16/2022]
Abstract
A Hybrid drug which comprises the incorporation of two drug pharmacophores in one single molecule are basically designed to interact with multiple targets or to amplify its effect through action on another bio target as one single molecule or to counterbalance the known side effects associated with the other hybrid part(.) The present review article offers a detailed account of the design strategies employed for the synthesis of anticancer agents via molecular hybridization techniques. Over the years, the researchers have employed this technique to discover some promising chemical architectures displaying significant anticancer profiles. Molecular hybridization as a tool has been particularly utilized for targeting tubulin protein as exemplified through the number of research papers. The microtubule inhibitors such as taxol, colchicine, chalcones, combretasatin, phenstatins and vinca alkaloids have been utilized as one of the functionality of the hybrids and promising results have been obtained in most of the cases with some of the tubulin based hybrids exhibiting anticancer activity at nanomolar level. Linkage with steroids as biological carrier vector for anticancer drugs and the inclusion of pyrrolo [2,1-c] [1,4]benzodiazepines (PBDs), a family of DNA interactive antitumor antibiotics derived from Streptomyces species in hybrid structure based drug design has also emerged as a potential strategy. Various heteroaryl based hybrids in particular isatin and coumarins have also been designed and reported to posses' remarkable inhibitory potential. Apart from presenting the design strategies, the article also highlights the structure activity relationship along with mechanistic insights revealed during the biological evaluation of the hybrids.
Collapse
|
19
|
Kumbhare RM, Dadmal TL, Devi TA, Kumar D, Kosurkar UB, Chowdhury D, Appalanaidu K, Rao YK, Ramaiah MJ, Bhadra MP. Isoxazole derivatives of 6-fluoro-N-(6-methoxybenzo[d]thiazol-2-yl)benzo[d]thiazol-2-amine and N-(pyrimidin-2-yl)benzo[d]thiazol-2-amine: regulation of cell cycle and apoptosis by p53 activation via mitochondrial-dependent pathways. MEDCHEMCOMM 2014. [DOI: 10.1039/c4md00279b] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The compounds depicted were shown to induce DNA damage and activate p53, which in turn activates Bax and decreases Bcl2 levels. This resulted in apoptosis in Colo205 cells.
Collapse
Affiliation(s)
| | - Tulshiram L. Dadmal
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - T. Anjana Devi
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - Dinesh Kumar
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - Umesh B. Kosurkar
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - Debabrata Chowdhury
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - K. Appalanaidu
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - Y. Khageswara Rao
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad, India
| | - M. Janaki Ramaiah
- School of Chemical and Biotechnology
- Sastra University
- Thanjavur-613401, India
| | - Manika Pal Bhadra
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad, India
| |
Collapse
|
20
|
Zhang Y, Wang S, Wu S, Zhu S, Dong G, Miao Z, Yao J, Zhang W, Sheng C, Wang W. Facile construction of structurally diverse thiazolidinedione-derived compounds via divergent stereoselective cascade organocatalysis and their biological exploratory studies. ACS COMBINATORIAL SCIENCE 2013; 15:298-308. [PMID: 23614347 DOI: 10.1021/co400022r] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
In this article, we present a new approach by merging two powerful synthetic tactics, divergent synthesis and cascade organocatalysis, to create a divergent cascade organocatalysis strategy for the facile construction of new "privileged" substructure-based DOS (pDOS) library. As demonstrated, notably 5 distinct molecular architectures are produced facilely from readily available simple synthons thiazolidinedione and its analogues and α,β-unsaturated aldehydes in 1-3 steps with the powerful strategy. The beauty of the chemistry is highlighted by the efficient formation of structurally new and diverse products from structurally close reactants under the similar reaction conditions. Notably, structurally diverse spiro-thiazolidinediones and -rhodanines are produced from organocatalytic enantioselective 3-component Michael-Michael-aldol cascade reactions of respective thiazolidinediones and rhodanines with enals. Nevertheless, under the similar reaction conditions, reactions of isorhodanine via a Michael-cyclization cascade lead to structurally different fused thiopyranoid scaffolds. This strategy significantly minimizes time- and cost-consuming synthetic works. Furthermore, these molecules possess high structural complexity and functional, stereochemical, and skeletal diversity with similarity to natural scaffolds. In the preliminary biological studies of these molecules, compounds 4f, 8a, and 10a exhibit inhibitory activity against the human breast cancer cells, while compounds 8a, 9a, and 9b display good antifungal activities against Candida albicans and Cryptococcus neoformans. Notably, their structures are different from clinically used triazole antifungal drugs. Therefore, they could serve as good lead compounds for the development of new generation of antifungal agents.
Collapse
Affiliation(s)
- Yongqiang Zhang
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Shengzheng Wang
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Shanchao Wu
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Shiping Zhu
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Guoqiang Dong
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Zhenyuan Miao
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Jianzhong Yao
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Wannian Zhang
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Chunquan Sheng
- Department of Medicinal Chemistry,
School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, P. R. China
| | - Wei Wang
- Department of Chemistry and
Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131-0001, United States
- School of Pharmacy, East China University of Science and Technology, Shanghai
200237, P. R. China
| |
Collapse
|